Tag Archives: Akebia Therapeutics Inc.

US stock market has a subdued Thanksgiving week, but a slew of healthcare companies rocketed higher.

Here’s the blistering action on the Nasdaq from last week, with four of the top gainers and one of the sorely downtrodden: ChemoCentryx Inc. (Nasdaq:CCXI) led advancing issues, skyrocketing 282%… Read more »

Akebia surges on anemia drug deal; is a much bigger breakout looming?

The News: Akebia Therapeutics Inc. (Cambridge MA) leaped 18% Tuesday (May 16, 2017) sparked by news the fledgling dialysis treatment developer and Swiss backer Vifor Pharma Group Ltd. (Glattburg) agreed… Read more »

Akebia shares soar on rich partnership with Otsuka; risky but rational gamble?

The News: Akebia Therapeutics Inc. (Nasdaq:AKBA) led advancing issues last week, soaring $4.08, or 45% for the 5-day stretch, to $13.18. The big move came after the Cambridge, MA-based company… Read more »